These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19865180)

  • 21. Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts.
    Loiler SA; Tang Q; Clarke T; Campbell-Thompson ML; Chiodo V; Hauswirth W; Cruz P; Perret-Gentil M; Atkinson MA; Ramiya VK; Flotte TR
    Mol Ther; 2005 Sep; 12(3):519-27. PubMed ID: 15979413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA
    Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Function of a long-term, GLP-1-treated, insulin-secreting cell line is improved by preventing DPP IV-mediated degradation of GLP-1.
    Green BD; Liu HK; McCluskey JT; Duffy NA; O'Harte FP; McClenaghan NH; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):563-9. PubMed ID: 16050949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes.
    Glauser DA; Brun T; Gauthier BR; Schlegel W
    BMC Mol Biol; 2007 Jun; 8():54. PubMed ID: 17587450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
    Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes.
    Gaddy DF; Riedel MJ; Pejawar-Gaddy S; Kieffer TJ; Robbins PD
    Diabetes; 2010 Dec; 59(12):3108-16. PubMed ID: 20841608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes.
    Yang SJ; Choi JM; Kim L; Kim BJ; Sohn JH; Kim WJ; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Kim SW; Park CY
    Biochem Biophys Res Commun; 2011 Apr; 407(1):153-7. PubMed ID: 21371430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy.
    Chen NK; Tan SY; Udolph G; Kon OL
    Gene Ther; 2010 May; 17(5):592-605. PubMed ID: 20182520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 16,17-Dihydro-17b-hydroxy isomitraphylline alkaloid as an inhibitor of DPP-IV, and its effect on incretin hormone and β-cell proliferation in diabetic rat.
    Shukla A; Srinivasan BP
    Eur J Pharm Sci; 2012 Sep; 47(2):512-9. PubMed ID: 22820565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth factor signalling in the regulation of α-cell fate.
    Kawamori D; Akiyama M; Hu J; Hambro B; Kulkarni RN
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():21-30. PubMed ID: 21824253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice.
    Vasu S; Moffett RC; McCluskey JT; Hamid MH; Irwin N; Flatt PR
    Gene Ther; 2013 Nov; 20(11):1077-84. PubMed ID: 23784442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
    Flores RR; Zhou L; Robbins PD
    Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glucagon-like peptide-1 gene expression on graft function in mouse islet transplantation.
    Chae HY; Kang JG; Kim CS; Lee SJ; Lee M; Kang D; Jun HS; Ihm SH
    Transpl Int; 2012 Feb; 25(2):242-9. PubMed ID: 22171669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15.
    Puddu A; Storace D; Durante A; Odetti P; Viviani GL
    Biochem Biophys Res Commun; 2010 Jul; 398(3):462-6. PubMed ID: 20599702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
    Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
    J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
    Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
    Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
    Fosgerau K; Jessen L; Lind Tolborg J; Østerlund T; Schæffer Larsen K; Rolsted K; Brorson M; Jelsing J; Skovlund Ryge Neerup T
    Diabetes Obes Metab; 2013 Jan; 15(1):62-71. PubMed ID: 22862961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin.
    Iida A; Seino Y; Fukami A; Maekawa R; Yabe D; Shimizu S; Kinoshita K; Takagi Y; Izumoto T; Ogata H; Ishikawa K; Ozaki N; Tsunekawa S; Hamada Y; Oiso Y; Arima H; Hayashi Y
    Diabetologia; 2016 Jul; 59(7):1533-1541. PubMed ID: 27053237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholinesterase is associated with apoptosis in β cells and contributes to insulin-dependent diabetes mellitus pathogenesis.
    Zhang B; Yang L; Yu L; Lin B; Hou Y; Wu J; Huang Q; Han Y; Guo L; Ouyang Q; Zhang B; Lu L; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):207-16. PubMed ID: 22236578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLP-1-mediated gene therapy approaches for diabetes treatment.
    Tasyurek MH; Altunbas HA; Canatan H; Griffith TS; Sanlioglu S
    Expert Rev Mol Med; 2014 Mar; 16():e7. PubMed ID: 24666581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.